The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation

Free Radical Research

Volumn 44, Issue 5, 2010, Pages 529-540

  Thompson, John S ^a,b   Chu, Yanxia ^b   Glass, Judith ^b   Tapp, Andrea A ^b   Brown, Stephen A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bowel; Lymphoid; M40403; Protection; Radiation

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); RADIOPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG STRUCTURE; GENE OVEREXPRESSION; GRANULOPOIESIS; HEMATOPOIETIC TISSUE; HISTOPATHOLOGY; LETHALITY; LYMPHOID TISSUE; MALE; MOUSE; NICK END LABELING; NONHUMAN; RADIATION INJURY; RADIATION PROTECTION; SURVIVAL; WHOLE BODY RADIATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BIOMIMETIC MATERIALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEMATOPOIETIC SYSTEM; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; RADIATION-PROTECTIVE AGENTS; SUPEROXIDE DISMUTASE; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

ANIMALIA; MUS;

EID: 77951267661     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715761003649578     Document Type: Article

References (36)

1. Wong GHW, Kaspar RL, Vehar G. Tumor necrosis factor and lymphotoxin: protection against oxidative stress through induction of MnSOD. EXS 1996;77:321-333.
2. Lebovitz RM, Zhang H, Vogel J, Cartwright L, Dionne N, Lu N, Huang S, Matzuk NM. Neurodegeneration, myocar-dial injury, and perinatal death in mitochondrial superoxide-defi cient mice. Proc Natl Acad Sci USA1999;93:9782-9787.
3. Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res 2001; 34:325-336. (Pubitemid 32331659)
4. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, infl am-mation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-159. (Pubitemid 32173112)
5. Epperly MW, Epstein CJ, Travis E, Greenberger JS. Decreased pulmonary radiation resistance of manganese superoxide dis-mutase (MnSOD)-defi cient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) in tracheal gene therapy. Radiat Res 2000;154:365-374.
6. Epperly MW, Tyurina YY, Nie S, Niu YY, Zhang X, Kagan K, Greenberger JS. MnSOD-plasmid liposome gene therapy decreases ionizing irradiation-induced lipid peroxidation of the esophagus. In-Vivo 2005;19:997-1004. (Pubitemid 41631501)
7. Masini E, Cuzzocrea S, Mazzon E, Marzocca C, Mannaioni PF, Salvelmini D. Protective effects of M40403, a selective super-oxide dismutase mimetic, in myocardial ischemia and reper-fusioin injury. Br J Pharmacol 2002;136:905-917. (Pubitemid 34836865)
8. Guo HL, Wolfe D, Epperly MW, Huang S, Liu K, Glorioso JC, Greenberger J, Blumberg D. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg 2003;7:229-235. (Pubitemid 36875792)
9. Salvemini D, Wang Z-Q, Sweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, Riley DP. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999;286:304-306. (Pubitemid 29484695)
10. Salvemini D, Muscoli C, Riley DP, Cuzzocrea S. 2002. Superoxide dismutase mimetics. Pulmonary Pharmocol Ther 2002;15:439-447. (Pubitemid 35333889)
11. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D. Inactivation of catacholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA 2000;9:9753-9758. (Pubitemid 30650848)
12. Mcinnis J, Wang C, Anastasio N, Huffman M, Ye YP, Salvemini D, Johnson KM. The role of superoxide and nuclear factor kappa B signaling in N-methyl-D-asparta-induced necrosis and apoptosis. J Pharmacol Exp Ther 2002;301: 478-487. (Pubitemid 34429957)
13. Currizoni S, Masson E, Dugo L, Paola R, Caputi AP, Salvemini D. Superoxide: a key player in hypertension. FASEB J 2004;18:94-101. (Pubitemid 38076469)
14. Lysiak JJ, Nguyen QAT, Turner TT. Peptide and nonpeptide reactive oxygen scavengers provide partial rescue of the testis after torsion. J Andrology 2002;2:400-409.
15. Cassatt DR, Fazenbaker CA, Kifl e G, Bachy CM. Preclinical studies of the radioprotective effi cacy and pharmacokinetics of subcutaneously administered amifostine. Semin Oncol 2002;29:2-8.
16. Grdina DJ, Murley JS, Kataoka Y. Radioprotectants: current status and new directions. Oncology 2002;63(suppl 2):2-10. (Pubitemid 36005577)
17. Romano MR, Lamberti AN, Bisogni R, Garbi C, Pagnano AM, Auletta P, Tassone P, Turco MC, Venuta S. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-κB/Rel transcription factors. Blood 1999;94:4060-4066.
18. Murley JS, Kataoka Y, Hallahan DE, Roberts JC, Grdina DJ. Activation of NF-κB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med 2001;12:1426-1439. (Pubitemid 32522958)
19. Murley JS, KataokaY, Cao D, Li JJ, Oberley LW, Grdina DJ. Delayed radioprotection by NF-κB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res 2004; 162:536-546.
20. Kahl R, Kampkotter A, Watjen W, Chovolou Y. Antioxi-dant enzymes and apoptosis. Drug Metab Rev 2004;36: 747-762.
21. Pani G, Bedogni B, Anzevino R, Colavitti R, Palazzotti B, Borrello S, Galeotti T. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-defi cient cells. Cancer Res 2000;60:4654-4660. (Pubitemid 32106655)
22. Dhar SK, Xu Y, Chen Y, St-Clair DK. Specifi city protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 2006; 281:21698-21709. (Pubitemid 44181873)
23. Weiss JF, Hoover RL, Kumar KS. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721. Free Radic Res Comm 1987;3:33-36.
24. Brown DQ, Pittock JW, Rubiinstein JS. Early results of the screening program for radioprotectors. Int J Radiat Oncol Biol Phys 1982;8:565-570.
25. Roderick TH. The response of twenty-seven inbred strains of mice to daily doses of whole-body x-irradiation. Radiat Res 1963;20:631-639.
26. Okayasu R, Suctomi K, Yu y, Silver A, Bedford JS, Cox R, Ullrich RI. A defi ciency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res 2000;60:4342-4345.
27. Yu Y, Okayasu R, Weil MM, Silver A, McCarthy M, Zabriskie R, Long S, Cox R, Ulrich RL. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res 2001;61:1820-1824. (Pubitemid 32691991)
28. Sorenson JR. Bis(3,5-diisopropylsalicylato)copper(II), a potent radioprotectant with superoxide dismutase mimetic activity. J Med Chem 1984;27:1747-1749.
29. Srinivasan N, Doctrow S, Singh VJ, Whitnall MH. Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol Immunotoxicol 2008;30:271-290. (Pubitemid 351882925)
30. Burdelya L, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort, FL, Osterman AL, DiDonato JA, Feinstein E, Gudkov AV. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008;320:226-230. (Pubitemid 351521417)
31. Taylor CW, Wang LM, List AF, Fernandes D, Paine-Murrieta GD, Johnson CS, Capizzi RI. Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained. Eur J Cancer 1997;33:1693-1698. (Pubitemid 28123495)
32. List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL. Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors. Leukemia 1998;12:1596-1602. (Pubitemid 28470445)
33. Coppey LJ, Geollett JS,.Davidson EP, Dunlap JA, Lund LL, Salvemini D, Yorek MA. Effect of M40403 treatment of diabetic rats on endoneurial blood fl ow, motor nerve conduction velocity, and vascular function of epineurial arterioles of the sciatic nerve. Br J Pharmacol 2001;134:21-29. (Pubitemid 32835464)
34. Wang Z-Q, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, Muscoli C, Mollace V, Ndengele, M, Salvemini D. A newly identifi ed role for superoxide in infl ammatory pain. J Pharmacol Exp Ther 2004;309:869-878. (Pubitemid 38669673)
35. Cuzzocrea S, Mazzon E, Dugo L, Di-Paloa R, Caputi AP, Salvemini D. Superoxide: a key player in hypertension. FASEB J 2004;18:94-101. (Pubitemid 38076469)
36. Voison EM, Ruthsatz M, Collins JM, Hoyle PC. Extrapolation of animal toxicity in humans: interspecies comparisons in drug development. Regulat Toxicol Pharmacol 1990;12:107-116. (Pubitemid 20337293)